PATENT CLAIM ANALYSIS

Application Number: 16274132
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["424", "181100"]

Abstract:
Benzazepine compounds, conjugates, and pharmaceutical compositions for use in the treatment of disease, such as cancer, are disclosed herein. The disclosed benzazepine compounds are useful, among other things, in the treating of cancer and modulating TLR8. Additionally, benzazepine compounds incorporated into a conjugate with an antibody construct are described herein.

Claim (Index 27):
The compound or salt of  claim 25 , wherein R 5  is selected from an optionally substituted fused 5-5, fused 5-6, and fused 6-6 bicyclic heterocycle.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 99.0
- Lexical Diversity: 1.5
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16274130', '15774262', '15973506', '15509989', '10493279']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8155956853527006
- 35 USC 102 Novelty (BERT): 0.6054658332414485
- Combined Prediction Score: 0.7945827001415754
- Mean Citation Score: 477.541558
- Max Citation Score: 547.21844
- Similarity Product: 490.1224415564656

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test